Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tucci

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|February 20, 2004
Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonistsZhiqiang Guo, Yun-Fei Zhu, Timothy D Gross, et al.
Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|November 14, 2008
Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptorChen Chen, Dongpei Wu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Journal of Medicinal Chemistry|June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazinesFabio C Tucci, Nicole S White, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Said Zamani-Kord, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|February 20, 2004
Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonistsZhiqiang Guo, Yun-Fei Zhu, Timothy D Gross, et al.
Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|November 14, 2008
Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptorChen Chen, Dongpei Wu, Zhiqiang Guo, et al.
Journal of Medicinal Chemistry|February 18, 2005
3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterizationFabio C Tucci, Yun-Fei Zhu, R Scott Struthers, et al.
Bioorganic & Medicinal Chemistry|April 18, 2008
Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonistsChen Chen, Fabio C Tucci, Wanlong Jiang, et al.
Journal of Medicinal Chemistry|November 13, 2007
Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptorJoe A Tran, Wanlong Jiang, Fabio C Tucci, et al.
Journal of Medicinal Chemistry|June 25, 2004
3-(2-aminoalkyl)-1-(2,6-difluorobenzyl)-5- (2-fluoro-3-methoxyphenyl)-6-methyl-uracils as orally bioavailable antagonists of the human gonadotropin releasing hormone receptorFabio C Tucci, Yun-Fei Zhu, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazinesFabio C Tucci, Nicole S White, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Said Zamani-Kord, et al.
Pageof 9